Loges, S., Heuser, M., Chromik, J., Sutamtewagul, G., Kapp-Schwoerer, S., Crugnola, M., . . . Gjertsen, B. T. (2025). Bemcentinib as monotherapy and in combination with low-dose cytarabine in acute myeloid leukemia patients unfit for intensive chemotherapy: A phase 1b/2a trial. Nature Communications, 16, . https://doi.org/10.1038/s41467-025-58179-6
Chicago-Zitierstil (17. Ausg.)Loges, Sonja, et al. "Bemcentinib as Monotherapy and in Combination with Low-dose Cytarabine in Acute Myeloid Leukemia Patients Unfit for Intensive Chemotherapy: A Phase 1b/2a Trial." Nature Communications 16 (2025). https://doi.org/10.1038/s41467-025-58179-6.
MLA-Zitierstil (9. Ausg.)Loges, Sonja, et al. "Bemcentinib as Monotherapy and in Combination with Low-dose Cytarabine in Acute Myeloid Leukemia Patients Unfit for Intensive Chemotherapy: A Phase 1b/2a Trial." Nature Communications, vol. 16, 2025, https://doi.org/10.1038/s41467-025-58179-6.